Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06120608 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evidence for Potassium Restriction in Hemodialysis

Study acronym: EvoKe-HD
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 16, 2025 (before its estimated March 12, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoints revised (2)v5 Show 7 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: 60 to 50
    • Primary and study completion dates: Apr 30, 2026 to Mar 12, 2026
    • Eligibility criteria expanded, about 28 words
    • Secondary endpoints: 33 to 31
    • Study description revised
    • Site details revised
  2. Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Dec 30, 2027 to Apr 30, 2026
    • Start date changed from estimate of Apr 22, 2025 to Jun 17, 2025
    • Site details revised
    v4
  3. Primary and study completion dates: Dec 30, 2026 to Dec 30, 2027
    • Start date: Apr 22, 2024 to Apr 22, 2025
    v3
  4. Start date: Jan 2024 to Apr 22, 2024v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
EvoKe-HD is a pilot randomized controlled trial to assess the feasibility and potential for efficacy of a novel dietary approach to hyperkalemia. Contrary to the traditional recommendations limiting the intake of high-potassium whole foods, such as fruits and vegetables, the investigators propose to switch the focus to foods containing potassium that is readily absorbed by the body (high bioavailability), such as potassium from additives, processed meats, milk, fruit juices and sugary drinks.
Trial Details
NCT Number NCT06120608
Lead Sponsor Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
Collaborators: Canadian Institutes of Health Research (CIHR)
Conditions
(from sponsor)		 Hyperkalemia, Diminished Renal Excretion
Related terms Hyperkalemia
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov